Hepatitis B Market Forecast
This model contains a ten year commercial forecast of hepatitis B drug sales by country, class, molecule and brand across the US, Japan, France, Germany, Italy, Spain, UK and Turkey.
Reasons... |
Antithrombotics
Competitor Analysis
Product description
The Competitive Intelligence Report Antithrombotics as of August 2008 provides a competitor analysis in the development pipeline of novel anticoagulants and antiplatelet agents for prophylaxis and treatment of venous... |
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Summary
GlobalData's report, ""Failure of TAK442 to... |
The Cardiovascular Market Outlook to 2016
Healthcare
Introduction
The large number of impending patent expirations of blockbuster drugs will negatively impact the cardiovascular pharmaceutical segment. Evolving strategies in this segment such as in-licensing of drug candidates, and... |
Obesity Market Forecast
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly... |
Antipsychotics Market Forecast
Healthcare
Introduction
In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in... |
HIV Market Forecast
In 2009, HIV antiretroviral sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations will... |
Brazil Generics Market Forecast to 2012
Since the initial launch of policies, Brazil generic drugs market has been experiencing a stupendous growth. The country is the largest generics market in Latin America and is poised to... |
Insomnia Market Forecast
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market. Following... |
Acute Coronary Syndrome
This report analyzes the global market for Acute Coronary Syndrome Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 60... |
Schizophrenia Market Forecast
Despite imminent generic erosion of blockbuster brands, the schizophrenia market will retain its value, supported by the uptake of premium priced depot formulations and new pipeline therapies to offset the... |
Cardiovascular Therapeutic Drugs: Technologies and Global Markets
This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to... |
Inflammatory Bowel Disease Market Forecast
This model provides detailed sales and volume forecast data for the inflammatory bowel disease market. Including Crohn's disease and ulcerative colitis market sizing, within the context of total brand sales... |
Global Pharmaceutical Market Forecast to 2012
The pharmaceutical market worldwide, after experiencing a slump during the past 2 years, is now in its recovery period, which will be followed by its growth. Decline in global pharma... |
Cytotoxic Therapies Market Forecast
Growth of cytotoxics will remain static over the forecast period with a CAGR of -0.1%. Several blockbuster products are due to undergo patent expiry over the forecast period and the... |
Multiple Sclerosis Market Forecast
Introduction
With FDA advisory board support for Gilenia (fingolimod), Novartis will move ahead of Merck Serono's oral cladribine in the race to become the first oral multiple sclerosis therapy. Although growth... |
Stakeholder Opinions: Heart Failure
When drugs do not work
Introduction
Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view... |
Migraine Market Forecast
Introduction
After 4 years of steady growth, the migraine market across the seven major regions was valued at $4.6 billion in 2008. However, following US patent expiries of both the acute... |
Osteoporosis Market Forecast
Introduction
Globally, the osteoporosis market displayed a 3.5% compound annual growth rate (CAGR) between 2005-09, reaching $9.4 billion in 2009. However, the launch of generic alendronate in the majority of markets... |
Latin American Cardiovascular Drugs Markets
This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which... |
Asthma/COPD Market Forecast
Introduction
This model contains a 10 year country, indication, and device specific forecasts for individual products used in asthma and COPD, taking into account competitive positioning and key market events.
Reasons to... |
Cardiovascular Drugs
This report analyzes the worldwide markets for Cardiovascular Drugs in US$ Million. Cardiovascular diseases can be prevented or treated using different classes of drugs. Broadly, the major classes of cardiovascular... |
Parkinson's Disease Market Forecast
In 2009, the Parkinson's disease market generated $2.2bn across the seven major markets. As the market approaches maturity, Datamonitor forecasts the growth to slow from a compound annual growth rate... |
Fibromyalgia Market Forecast
Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for... |
Urinary Incontinence Market Forecast
The urinary incontinence drug market has been displaying strong growth from 2005-09 owing to the uptake of new products driven by large marketing campaigns. Promotional efforts will remain integral to... |
